Abstract
Purpose of Review
We explicate the development of cystic lung disease from the deposition of protein in the lung. The protein may be in the form of amyloid or non-amyloid (typically immunoglobulin-associated light chains) and is usually seen in the context of three entities: idiopathic light-chain deposition disease, Sjogren’s syndrome, and clonal lymphoplasmacytic proliferative disorders. A commonly observed and distinctive feature of the circumscribed cystic spaces is the presence of internal tissue septations.
Recent Findings
The traditional causal association of lung cysts and the pathologic entity of lymphocytic interstitial pneumonitis is untenable. Instead, the development of cysts as a consequence of the degradation of lung extracellular matrix by metalloproteinases, the process initiated with the accumulation of macrophages around deposited protein, is a compelling alternative explanation.
Summary
Lung cysts may be a consequence of parenchymal protein deposition. When internal septations are present, this particular pathogenesis should explicitly be considered, and the presence of associated clinical disorders further pursued.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Recently published papers of particular interest have been highlighted as: • Of importance
Colombat M, Stern M, Groussard O, Droz D, Brauner M, Valeyre D, et al. Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med. 2006;173:777–80. https://doi.org/10.1164/rccm.200510-1620cr.
Lee YL, Hoffman D, Balk RA. Metastatic medullary thyroid carcinoma presenting as pulmonary amyloidosis. Chest. 2006;130(S):335S. https://doi.org/10.1378/chest.130.4_meetingabstracts.336s-b.
Khoor A, Colby TV. Amyloidosis of the lung. Arch Pathol Lab Med. 2017;141:247–54. https://doi.org/10.5858/arpa.2016-0102-RA.
Ichikawa Y, Kinoshita M, Koga T, Oizumi K, Fujimoto K, Hayabuchi N. Lung cyst formation in lymphocytic interstitial pneumonia: CT features. J Comput Assist Tomogr. 1994;18:745–8.
Jeong YJ, Lee KS, Chung MP, Han J, Chung MJ, Kim KI, et al. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr. 2004;28:776–81.
• Baqir M, Kluka EM, Aubry M, Hartman TE, Eunhee SY, Bauer PR, et al. Amyloid-associated cystic lung disease in primary Sjogren’s syndrome. Respir Med. 2013;107:616–21. https://doi.org/10.1016/j.rmed.2013.01.005. This important pathology report demonstrates the universal presence of amyloid, and no instances of lymphocytic interstitial pneumonitis, in a cohort of patients with Sjogren’s syndrome and cystic lung disease.
Arossi AV, Merzianu M, Farver C, Yuan C, Wang SH, Nakashima MO, et al. Nodular pulmonary light chain deposition disease: an entity associated with Sjögren syndrome or marginal zone lymphoma. J Clin Pathol. 2016;69:490–6. https://doi.org/10.1136/jclinpath-2015-203342.
Burgess JK, Mauad T, Tjin G, Karlsson J, Westergren-Thorsson G. The extracellular matrix—the under-recognized element in lung disease? J Pathol. 2016;240:397–409. https://doi.org/10.1002/path.4808.
Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev. 2007;87:69–98. https://doi.org/10.1152/physrev.00022.2006.
• Colombat M, Caudroy S, Lagonotte E, Mal H, Danel C, Stern M, et al. Pathomechanisms of cyst formation in pulmonary light chain deposition disease. Eur Respir J. 2008;32:1399–403. https://doi.org/10.1183/09031936.00132007. This is a seminal reference for this manuscript, in which the authors propose a plausible pathomechanism for the development of lung cysts as a consequence of protein deposition.
• Girard N, Vasiljevic A, Cottin V, Falchero L, Meyronet D, Thivolet-Bejui F, et al. Respiratory failure with diffuse bronchiectases and cryoglobulinaemia. Eur Respir J. 2008;31:1374–8. https://doi.org/10.1183/09031936.00004408. The image of bronchiectasis in this paper matches those of the three cases of bronchiectasis we present.
Cornec D, Devauchelle-Pensec V, Tobón GJ, Jacques-Olivier P, Jousse-Joulin S, Saraux A. B cells in Sjögren’s syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun. 2012;39:161–7. https://doi.org/10.1016/j.jaut.2012.05.014.
• Colombat M, Mal H, Diebold J, Copie-Bergman C, Damotte D, Callard P, et al. Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor. Blood 2008;112:2004–12. https://doi.org/10.1182/blood-2007-11-123596. This demonstrates an important concept: the clonal, protein-producing lymphocytes may be confined to the lung.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Leif Jensen and Howard Mann each declare no potential conflicts of interest.
Human and Animal Rights and Informed Consent
The article content does not relate to any studies with animal or human subjects performed by any of the authors.
Additional information
This article is part of the Topical collection on Chest Imaging.
Rights and permissions
About this article
Cite this article
Jensen, L., Mann, H. Cystic Lung Disease from Protein Deposition: Pathogenesis and Associated Conditions. Curr Radiol Rep 6, 12 (2018). https://doi.org/10.1007/s40134-018-0271-y
Published:
DOI: https://doi.org/10.1007/s40134-018-0271-y